Comparative Proteomics to Study Age-Related Maculopathy
研究年龄相关性黄斑病的比较蛋白质组学
基本信息
- 批准号:7922280
- 负责人:
- 金额:$ 6.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2010-09-29
- 项目状态:已结题
- 来源:
- 关键词:AftercareAgeAge related macular degenerationAmino AcidsAngiogenic FactorAntibodiesAreaAtrophicAutopsyBasal laminaBindingBiochemical PathwayBiogenesisBlindnessBlood VesselsBruch&aposs basal membrane structureCatalogingCatalogsCell AgingCell Culture TechniquesCell FractionationCellsCharacteristicsChoroidChoroidal NeovascularizationClinicalCollaborationsComplementComplement Factor HComputer softwareCulture MediaCytoskeletonDataDepositionDevelopmentDiagnosisDiseaseDisease ProgressionDoseDrusenElderlyEnvironmental Risk FactorEpidemiologic StudiesEyeFractionationFunctional disorderFutureGeneticGenetic PolymorphismGenetic VariationGenotypeGoalsHandHumanHydroquinonesInflammationInflammation MediatorsInflammatoryInjuryInterleukin-1LabelLeadLinkLiteratureMass Spectrum AnalysisMeasurementMediatingMetabolicMethodologyModelingMolecularMonitorPathogenesisPathologyPathway AnalysisPathway interactionsPatientsPatternPhenotypePhotoreceptorsPlayPopulationPredispositionPrincipal InvestigatorProtein SecretionProteinsProteomeProteomicsReportingRetinaRetinal DegenerationRiskRoleSamplingSerumSpecific qualifier valueStable Isotope LabelingStressStructureStructure of retinal pigment epitheliumSubcellular FractionsSurfaceSystemTNF geneTechniquesTestingVariantWestern Blottingangiogenesisarginyllysinebasecell agecell typecomparativecytokineenvironmental stressorhydroquinoneimprovedmaculanew therapeutic targetnormal agingpreventprogramsprotein expressionprotein profilingreceptorresearch studyresponsestable isotopesulfated glycoprotein 2trafficking
项目摘要
While the genetic factors responsible for age related macular degeneration (AMD) are becoming unraveled, the pathophysiology of the disease remains difficult to understand. AMD is characterized by an accumulation of drusen between the basal lamina of the retinal pigment epithelium (RPE) and Bruch's membrane resulting in progressive degeneration of RPE cells and photoreceptors. Understanding the cellular and molecular origins of drusen will help in finding new therapeutic targets to prevent or slow down the progression of the disease. The objective of this study is to determine the role of RPE cells in drusen formation. The underlying hypothesis is that RPE cells are involved in drusen formation and that an aberrant response of RPE from AMD donors to different environmental stressors is a cause of drusen accumulation. Protein expression patterns and especially proteins secreted by RPE cells, detectable by proteomic techniques, are expected to be a direct reflection of the relationship between RPE cells and drusen formation. Using a cutting edge proteomics approach (stable isotope labeling by amino acids) we show that RPE cells secrete a variety of proteins that have been reported to be major constituent of drusen. Additionally, our data reveals that RPE cells from AMD donors (diagnosed by histological examinations of the macula and genotyped for the Y402H-CFH variant) secreted 2 to 3 fold more of these proteins than RPE from age matched healthy donors. In Specific Aim I, we will determine differentially expressed proteins between AMD RPE and healthy RPE using quantitative proteome profiling. We will focus on secreted proteins but eventually other subcellular fraction will be analyzed for comprehensive comparative proteomics. In Specific Aim II, changes in protein secretion in AMD RPE cells versus healthy RPE cells will be monitored following oxidative and/or inflammatory mediated injury. Overall, the results will help identify abnormal protein expression and trafficking associated with AMD pathogenesis in the retinal pigment epithelial cells. We anticipate that the application of newly emerging proteomic techniques will result in an improved understanding of the pathways involved in AMD pathogenesis and will help in finding new therapeutic targets to delay or stop progression of the disease. PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page Principal Investigator/Program Director (Last, First, Middle):Hathout, Yetrib The goal of this project is to study cellular and molecular mechanisms involved in age related macular degeneration (AMD) pathology. We will implement a proteomic approach to assess differential protein secretion in RPE cell cultures derived from AMD and age matched healthy donors.
虽然负责年龄相关性黄斑变性(AMD)的遗传因素正在逐渐解开,但该疾病的病理生理学仍然难以理解。AMD的特征是视网膜色素上皮(RPE)的基底层和Bruch膜之间的蛋白积累,导致RPE细胞和光感受器的进行性变性。了解drusen的细胞和分子起源将有助于找到新的治疗靶点,以预防或减缓疾病的进展。本研究的目的是确定RPE细胞在囊肿形成中的作用。潜在的假设是RPE细胞参与了囊肿的形成,AMD供体RPE对不同环境压力的异常反应是囊肿积累的原因。蛋白质组学技术可检测到的蛋白质表达模式,特别是RPE细胞分泌的蛋白质,有望直接反映RPE细胞与囊肿形成之间的关系。使用尖端的蛋白质组学方法(氨基酸稳定同位素标记),我们发现RPE细胞分泌多种蛋白质,这些蛋白质已被报道为drusen的主要成分。此外,我们的数据显示,来自AMD供者的RPE细胞(通过黄斑的组织学检查诊断,基因分型为Y402H-CFH变体)分泌的这些蛋白质比来自年龄匹配的健康供者的RPE多2至3倍。在Specific Aim I中,我们将使用定量蛋白质组分析来确定AMD RPE和健康RPE之间差异表达的蛋白质。我们将专注于分泌蛋白,但最终将分析其他亚细胞部分以进行全面的比较蛋白质组学。在Specific Aim II中,将监测氧化和/或炎症介导的损伤后AMD RPE细胞与健康RPE细胞中蛋白质分泌的变化。总之,这些结果将有助于识别视网膜色素上皮细胞中与AMD发病机制相关的异常蛋白表达和转运。我们预计,新出现的蛋白质组学技术的应用将导致对AMD发病机制的途径的更好理解,并将有助于找到新的治疗靶点来延缓或阻止疾病的进展。PHS 398/2590(09/04修订版,4/2006修订版)项目负责人/项目主任(最后,第一,中):Hathout, Yetrib该项目的目标是研究年龄相关性黄斑变性(AMD)病理的细胞和分子机制。我们将实施蛋白质组学方法来评估来自AMD和年龄匹配的健康供者的RPE细胞培养物的差异蛋白分泌。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of TNF-alpha on human ARPE-19-secreted proteins.
TNF-α 对人类 ARPE-19 分泌蛋白的影响。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:2.2
- 作者:An,Eunkyung;Gordish-Dressman,Heather;Hathout,Yetrib
- 通讯作者:Hathout,Yetrib
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YETRIB HATHOUT其他文献
YETRIB HATHOUT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YETRIB HATHOUT', 18)}}的其他基金
Biomarker discovery and validation in a Duchenne dystrophy natural history study
杜氏营养不良自然史研究中生物标志物的发现和验证
- 批准号:
8735609 - 财政年份:2011
- 资助金额:
$ 6.49万 - 项目类别:
Biomarker discovery and validation in a Duchenne dystrophy natural history study
杜氏营养不良自然史研究中生物标志物的发现和验证
- 批准号:
8330884 - 财政年份:2011
- 资助金额:
$ 6.49万 - 项目类别:
Biomarker discovery and validation in a Duchenne dystrophy natural history study
杜氏营养不良自然史研究中生物标志物的发现和验证
- 批准号:
8250248 - 财政年份:2011
- 资助金额:
$ 6.49万 - 项目类别:
Biomarker discovery and validation in a Duchenne dystrophy natural history study
杜氏营养不良自然史研究中生物标志物的发现和验证
- 批准号:
8544782 - 财政年份:2011
- 资助金额:
$ 6.49万 - 项目类别:
Comparative Proteomics to Study Age-Related Maculopathy
研究年龄相关性黄斑病的比较蛋白质组学
- 批准号:
7452323 - 财政年份:2007
- 资助金额:
$ 6.49万 - 项目类别:
Comparative Proteomics to Study Age-Related Maculopathy
研究年龄相关性黄斑病的比较蛋白质组学
- 批准号:
7259290 - 财政年份:2007
- 资助金额:
$ 6.49万 - 项目类别:
Dissociation of efficacy from side effects of anti-inflammatory therapies in Duchenne muscular dystrophy
杜氏肌营养不良症抗炎治疗的疗效与副作用的分离
- 批准号:
9753021 - 财政年份:
- 资助金额:
$ 6.49万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 6.49万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 6.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 6.49万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 6.49万 - 项目类别:














{{item.name}}会员




